期刊文献+

肝癌转化治疗的进展

下载PDF
导出
摘要 我国原发性肝癌患者的病死率高,多数患者确诊时已失去手术根治的机会。如何对中晚期肝癌患者进行手术根治,是目前临床研究的焦点。近年来,随着介入治疗、放射治疗(简称放疗)、靶向药物、免疫检查点抑制剂等治疗方法的进展,肝癌的治疗效果不断提高,进而推动肝癌的转化治疗进入高速发展期。因此,如何选择肝癌转化治疗方案是肝脏外科医师面临的重要挑战。本文结合文献报道,对肝脏外科常用的肝癌转化治疗策略、方法进行综述,供国内外同行参考。
作者 林镇海 王鲁
出处 《上海医学》 CAS 2022年第4期276-282,共7页 Shanghai Medical Journal
  • 相关文献

参考文献10

二级参考文献105

  • 1Yin Lei,Lau Wan Yee,Wei-Ping Zhou.Multiple hepatocellular carcinomas: liver resection or transcatheter arterial chemoembolization?[J].Hepatobiliary Surgery and Nutrition,2019,8(5):519-521. 被引量:4
  • 2Fabrizio Panaro,Fabio Giannone,Benjamin Riviere,Olivia Sgarbura,Caterina Cusumano,Emmanuel Deshayes,Francis Navarro,Boris Guiu,Francois Quenet.Perioperative impact of liver venous deprivation compared with portal venous embolization in patients undergoing right hepatectomy: preliminary results from the pioneer center[J].Hepatobiliary Surgery and Nutrition,2019,8(4):329-337. 被引量:16
  • 3Kiminori Uka,Hiroshi Aikata,Shintaro Takaki,Hiroo Shirakawa,Soo Cheol Jeong,Keitaro Yamashina,Akira Hiramatsu,Hideaki Kodama,Shoichi Takahashi,Kazuaki Chayama.Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma[J].World Journal of Gastroenterology,2007,13(3):414-420. 被引量:50
  • 4Bruix J, Sherman M. Management of hepatocellular carcinoma: anupdate. Hepatology 2011; 53: 1020-1022 [PMID: 21374666 DOI:10.1002/hep.24199].
  • 5Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CACancer J Clin 2010; 60: 277-300 [PMID: 20610543 DOI: 10.3322/caac.20073].
  • 6Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A,Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L.Liver transplantation for the treatment of small hepatocellularcarcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693-699 [PMID: 8594428 DOI: 10.1056/NEJM199603143341104].
  • 7Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A,Ascher NL, Roberts JP. Liver transplantation for hepatocellularcarcinoma: expansion of the tumor size limits does not adverselyimpact survival. Hepatology 2001; 33: 1394-1403 [PMID:11391528 DOI: 10.1053/jhep.2001.24563].
  • 8Marsh JW, Dvorchik I. Liver organ allocation for hepatocellularcarcinoma: are we sure- Liver Transpl 2003; 9: 693-696 [PMID:12827554 DOI: 10.1053/jlts.2003.50086].
  • 9Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M,Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi GL, AdamR, Neuhaus P, Salizzoni M, Bruix J, Forner A, De Carlis L, Cillo U,Burroughs AK, Troisi R, Rossi M, Gerunda GE, Lerut J, Belghiti J,Boin I, Gugenheim J, Rochling F, Van Hoek B, Majno P. Predictingsurvival after liver transplantation in patients with hepatocellularcarcinoma beyond the Milan criteria: a retrospective, exploratoryanalysis. Lancet Oncol 2009; 10: 35-43 [PMID: 19058754].
  • 10D'Amico F, Schwartz M, Vitale A, Tabrizian P, Roayaie S, ThungS, Guido M, del Rio Martin J, Schiano T, Cillo U. Predictingrecurrence after liver transplantation in patients with hepatocellularcarcinoma exceeding the up-to-seven criteria. Liver Transpl 2009;15: 1278-1287 [PMID: 19790142 DOI: 10.1002/lt.21842].

共引文献4068

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部